Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly t(8;16). (A cytogenetic abnormality that involves a translocation between chromosomes 8 and 16.)
No clinical trials have been registered for acute myeloid leukemia, t(8;16).
6 publications have been identified in PubMed for acute myeloid leukemia, t(8;16). Research spans Case Report / Case Series (50%), Clinical Trial Publication (33%), and Review / Meta-Analysis (17%).
Catana AC (2026). [PMID: 41753246](https://pubmed.ncbi.nlm.nih.gov/41753246/). *J Clin Med*. [Case Report / Case Series]
Schmälter AK (2025). [PMID: 39558209](https://pubmed.ncbi.nlm.nih.gov/39558209/). *Am J Hematol*. [Clinical Trial Publication]
Shah S (2025). [PMID: 40750237](https://pubmed.ncbi.nlm.nih.gov/40750237/). *Ann Clin Lab Sci*. [Case Report / Case Series]
Bazarbachi A (2025). [PMID: 40445901](https://pubmed.ncbi.nlm.nih.gov/40445901/). *Am J Hematol*. [Clinical Trial Publication]
Spałek A (2024). [PMID: 38614931](https://pubmed.ncbi.nlm.nih.gov/38614931/). *Hematol Transfus Cell Ther*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 3:04 AM UTC
Common questions about acute myeloid leukemia, t(8;16)